Glucosamine

 Table of Content

I. SCOPE AND METHODOLOGY	1
II. REPORT SYNOPSIS	3
2.1 Introduction	3
Joint Supplements	3
Glucosamine	3
D-Glucosamine Hydrochloride (HCl)	4
Glucosamine Sulphate	4
N-Acetyl-Glucosamine (NAG)	5
Poly-N-Acetyl-Glucosamine (Poly NAG)	5
Glucosamine Acetyl	5
Chondroitin	6
Combination Supplements	6
Chitin and Chitinases	6
Methylsulfonylmethane (MSM, or Dimethylsulfone)	6
Uses of Glucosamine	7
2.2 Segmentation of Glucosamine Market	7
Exhibit 1. Segmentation of Global Glucosamine Market by Type, and by Application	7
2.3 Glucosamine - Global Market Analysis	8
Exhibit 2. Glucosamine – Global Value Market Analysis (2005 - 2020) in US$ Million	8
Exhibit 3. Glucosamine – Global Volume Market Analysis (2005 - 2020) in Thousand Metric Tons	9
Exhibit 4. List of Global Major Glucosamine Companies	10
III. MARKET DYNAMICS	11
3.1 Market Overview	11
3.2 Global Glucosamine Market	11
Exhibit 5. Glucosamine – Global Value Market Analysis (2005 - 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	12
Exhibit 6. Glucosamine – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	13
Exhibit 7. Glucosamine – Global Volume Market Estimations & Predictions (2011 - 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	14
Exhibit 8. Glucosamine – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	15
3.3 Asia-Pacific Glucosamine Market	16
Exhibit 9. Glucosamine – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific in US$ Million	16
Exhibit 10. Glucosamine – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific	17
Exhibit 11. Glucosamine – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific in Metric Tons	18
Exhibit 12. Glucosamine – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific	19
3.3 (I) Chinese Glucosamine Market	19
3.3 (II) Japanese Glucosamine Market	19
3.3 (III) Australian Glucosamine Market	20
3.3 (IV) Indian Glucosamine Market	20
3.3 (V) South Korean Glucosamine Market	20
Exhibit 13. List of Major Asia-Pacific Glucosamine Companies	20
3.4 North American Glucosamine Market	22
Exhibit 14. Glucosamine – North American Value Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in US$ Million	22
Exhibit 15. Glucosamine – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	23
Exhibit 16. Glucosamine – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	24
Exhibit 17. Glucosamine – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	25
3.4 (I) US Glucosamine Market	25
3.4 (II) Canadian Glucosamine Market	25
Exhibit 18. List of Major North American Glucosamine Companies	25
3.5 European Glucosamine Market	26
Exhibit 19. Glucosamine – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in US$ Thousands	26
Exhibit 20. Glucosamine – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	27
Exhibit 21. Glucosamine – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	28
Exhibit 22. Glucosamine – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	29
3.5 (I) UK Glucosamine Market	29
3.5 (II) German Glucosamine Market	29
3.5 (III) Spanish Glucosamine Market	29
3.5 (IV) Czech Glucosamine Market	30
3.5 (V) Russian Glucosamine Market	30
Exhibit 23. List of Major European Glucosamine Companies	30
3.6 Rest of World Glucosamine Market	31
Exhibit 24. Glucosamine – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in US$ Thousands	31
Exhibit 25. Glucosamine – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	32
Exhibit 26. Glucosamine – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in Metric Tons	33
Exhibit 27. Glucosamine – Rest of World Volume Market Shares (2010, 2015 & 2020) by Country South Africa, Brazil, Israel and Other Countries	34
3.6 (I) South African Glucosamine Market	34
3.6 (II) Brazilian Glucosamine Market	34
3.6 (III) Israeli Glucosamine Market	34
3.8 Global Companies in Glucosamine Industry	35
3.8.1 Producers of Glucosamine	35
A & Z Food Additives Co., Ltd. (China)	35
Amicogen, Inc. (South Korea)	35
Bayir Chemicals (India)	36
Cargill, Inc. (USA)	36
Coastal Laboratories (India)	37
Cyalume Specialty Products (USA)	37
Ethical Naturals, Inc. (USA)	38
Fraken Biochem Co., Ltd. (China)	38
Golden-Shell Pharmaceutical Co., Ltd. (China)	39
Hygieia Health Products (Hong Kong)	39
Koyo Chemical Company Limited (Japan)	40
Kraeber GmbH & Co. (Germany)	40
Lytone Enterprise, Inc. (Taiwan)	41
Newsmart (Nantong) Group (China)	41
Pacific Rainbow International, Inc. (USA)	42
Sai Gluco Pharma (India)	43
Shandong Yibao Biologics Co., Ltd. (China)	43
Shreeji Pharma International (India)	44
Shubhmets (India)	44
Sinochem Qingdao Co., Ltd. (China)	44
Sinoway International (Jiangsu) Co., Ltd. (China)	45
Stauber Performance Ingredients, Inc. (USA)	45
TSI Health Sciences (USA)	46
Wanbury Ltd. (India)	47
Wellable Group Marine Biological & Chemical Co., Ltd. (China)	47
Yaizu Suisankagaku Industry Co., Ltd. (Japan)	48
Zhejiang Aoxing Biotechnology Co., Ltd. (China)	48
Zhejiang Candorly Pharmaceutical Co., Ltd. (China)	49
Zhejiang Freemen Shinfuda Co., Ltd. (China)	50
Zhejiang Medicines & Health Products I/E Co., Ltd. (ZMC) (China)	51
3.8.2 Producers of Glucosamine Products	52
Aim Companies (The) (USA)	52
AniMed (USA)	52
Astamed Healthcare (I) Pvt. Ltd. (India)	53
Bio-Alternatives (USA)	53
Bioiberica SA (Spain)	54
DTC Health, Inc. (USA)	54
Norbrook Laboratories Ltd. (UK)	55
Nutri-Pet Research, Inc.  (USA)	57
Nutramax Laboratories, Inc. (USA)	58
Perrigo Company plc (Ireland)	59
Rottapharm | Madaus GmbH (Italy)	60
Seven Seas Ltd. (UK)	61
Synflex America, Inc. (USA)	62
Ultimate Nutrition (USA)	62
Unipharm, Inc. (USA)	63
3.9 Major Activities in Glucosamine Market	64
Health and Harmony LLC Launches Shellfish-Free Glucosamine that Naturally Reduces Joint Pain	64
Royal Canin® Expands Breed Health Nutrition™ Product Range through Addition of Beagle and West Highland White Terrier Nutrition Products	64
PetVitalix Launches Mobility CARE+, Glucosamine Supplement for Dogs	65
Bioberica Farma Launches Duartron® Glucosamine Capsules	65
Sergeant's Pet Care Products Launches Vetscription® Joint-Eze™	65
TSI Pharmaceuticals Expands with the Acquisition of National ProPack	66
IVC’s Glucosamine Preparation receives accreditation as Scientific Product by JSTD	66
Cargill, TSI Group Ltd. and TSI USA Inc., Change their Settlement Agreement Concerning Cargill’s Patented Technology	66
Nutramax Laboratories Launches Cosequin® and Dermaquin® for Dogs in Wal-Mart Store Nationwide	67
TSI Group Renames Its Australian Corporate Acquisition	67
TSI Group Completes Yessamin Ltd., Deal and Enhances the Existing China Base	68
Clinical Trial to Validate the Efficacy of Chondroitin Sulphate and Glucosamine Combination with over 450 Knee Osteoarthritis Patients	68
STAUBER Acquires Pharmline	69
Norbrook Presents Noroquin Range for Horses	69
Bioiberica Farma Concludes New Clinical Trial to Analyze the Efficiency and Safety of the Combination of Glucosamine and Chondroitin Sulfate	70
Bio Bodyfuelz’s Products Go Online after Tie-up with MyNutraMart.com	70
USPTO Approves Cargill’s Patent for Glucosamine Production Process	71
Bio-Glucosamine Forte Named the Leading Glucosamine in the Netherlands	71
Review Supports Safety of Glucosamine	72
Cargill Obtains Patent for Glucosamine Production Process	72
TSI declares GRAS Status for PUREFLEX® Chondroitin for application in Conventional Food products	72
LE Strengthens Position in Rheumatology with the Buyout of Navamedic’s Glucomed	73
Connectin® of In Clover, the Solitary Proven Safe Product in Crowded Joint Market	73
Convenient and Portable New Powder Format Packs from Elations	73
Cargill Finalizes Issues with Hygieia and TSI	73
Hygieia Unveils GlucosaGreen™, Range of Vegetarian and Vegan Glucosamine	74
NO DOL Muscle and Joint Cream	74
Triarco Unveils Liquid Glucosamine	74
Mega Lifesciences Introduces Glucosamine based Products	74
Bayer HealthCare to Acquire Sagmel Inc	75
Ethical Naturals Introduces 100% Vegetarian GreenGrown™ Glucosamine	75
Hygieia Health Launches New Vegetarian Glucosamine	75
William Ransom Unveils the Alateris	76
Navamedic Introduces Mobilat Glucosamin in Germany	76
William Ransom to Supply Navamedic's Glucomed, the only Approved Glucosamine Products Exclusively for 10 years in UK	77
Cargill Attains GRAS Status for REGENASURE® Glucosamine	77
Zylera Pharmaceuticals Introduces RELAMINE for Osteoarthritis Treatment	78
Glucomed/Flexove Attains EU Approval	78
Navamedic Signs an Agreement with PacificPharm for Supplying Glucomed in Korea	79
Zylera Commercializes RELAMINE	79
Lytone Buys Chitin from ChitiNor of Navamedic	80
Navamedic Signs an Agreement with Nergård Group	80
3.10 Analysis by Type	81
Exhibit 28. Glucosamine by Type - Global Value Market Analysis (2005-2020) for D-Glucosamine and N-Acetyl-Glucosamine in US$ Million	81
Exhibit 29. Glucosamine by Type – Global Value Market Shares (2010, 2015 & 2020) for D-Glucosamine and N-Acetyl-Glucosamine	82
Exhibit 30. Glucosamine by Type - Global Volume Market Analysis (2005-2020) for D-Glucosamine and N-Acetyl-Glucosamine in Metric Tons	83
Exhibit 31. Glucosamine by Type – Global Volume Market Shares (2010, 2015 & 2020) for D-Glucosamine and N-Acetyl-Glucosamine	84
3.10.1 D-Glucosamine	85
3.10.1.1 Global D-Glucosamine Market	85
Exhibit 32. D-Glucosamine – Global Value Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	86
Exhibit 33. D-Glucosamine – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	87
Exhibit 34. D-Glucosamine – Global Volume Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	88
Exhibit 35. D-Glucosamine – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	89
3.10.1.2 Asia-Pacific D-Glucosamine Market	90
Exhibit 36. D-Glucosamine – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific in US$ Million	90
Exhibit 37. D-Glucosamine – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific	91
Exhibit 38. D-Glucosamine – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific in Metric Tons	92
Exhibit 39. D-Glucosamine – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific	93
3.10.1.2 (I) Chinese D-Glucosamine Market	93
3.10.1.2 (II) Japanese D-Glucosamine Market	93
3.10.1.2 (III) Australian D-Glucosamine Market	93
3.10.1.2 (IV) Indian D-Glucosamine Market	94
3.10.1.2 (V) South Korean D-Glucosamine Market	94
Exhibit 40. List of Asia-Pacific D-Glucosamine Companies	94
3.10.1.3 North American D-Glucosamine Market	95
Exhibit 41. D-Glucosamine – North American Value Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in US$ Million	95
Exhibit 42. D-Glucosamine – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	96
Exhibit 43. D-Glucosamine – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	97
Exhibit 44. D-Glucosamine – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	98
3.10.1.3 (I) US D-Glucosamine Market	98
3.10.1.3 (II) Canadian D-Glucosamine Market	98
Exhibit 45. List of North American D-Glucosamine Companies	98
3.10.1.4 European D-Glucosamine Market	100
Exhibit 46. D-Glucosamine – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in US$ Thousands	100
Exhibit 47. D-Glucosamine – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	101
Exhibit 48. D-Glucosamine – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	102
Exhibit 49. D-Glucosamine – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	103
3.10.1.4 (I) UK D-Glucosamine Market	103
3.10.1.4 (II) German D-Glucosamine Market	103
3.10.1.4 (III) Spanish D-Glucosamine Market	103
3.10.1.4 (IV) Czech D-Glucosamine Market	104
3.10.1.4 (V) Russian D-Glucosamine Market	104
Exhibit 50. List of European D-Glucosamine Companies	104
3.10.1.5 Rest of World D-Glucosamine Market	105
Exhibit 51. D-Glucosamine – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for Israel, South African, Brazil and Other Countries in US$ Thousands	105
Exhibit 52. D-Glucosamine – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for Israel, South African, Brazil and Other Countries	106
Exhibit 53. D-Glucosamine – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for Israel, South African, Brazil and Other Countries in Metric Tons	107
Exhibit 54. D-Glucosamine – Rest of World Volume Market Shares (2010, 2015 & 2020) by Country for Israel, South African, Brazil and Other Countries	108
3.10.1.5 (I) South African D-Glucosamine Market	108
3.10.1.5 (II) Brazilian D-Glucosamine Market	108
3.10.1.5 (III) Israeli D-Glucosamine Market	108
3.10.2 N-Acetyl-Glucosamine	109
3.10.2.1 Global N-Acetyl-Glucosamine Market	109
Exhibit 55. N-Acetyl-Glucosamine – Global Value Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	109
Exhibit 56. N-Acetyl-Glucosamine – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	110
Exhibit 57. N-Acetyl-Glucosamine – Global Volume Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	111
Exhibit 58. N-Acetyl-Glucosamine – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World	112
3.10.2.2 Asia-Pacific N-Acetyl-Glucosamine Market	113
Exhibit 59. N-Acetyl-Glucosamine – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific in US$ Thousands	113
Exhibit 60. N-Acetyl-Glucosamine – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific	114
Exhibit 61. N-Acetyl-Glucosamine – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific in Metric Tons	115
Exhibit 62. N-Acetyl-Glucosamine – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India, South Korea and Rest of Asia-Pacific	116
3.10.2.2 (I) Chinese N-Acetyl-Glucosamine Market	116
3.10.2.2 (II) Japanese N-Acetyl-Glucosamine Market	116
3.10.2.2 (III) Australian N-Acetyl-Glucosamine Market	116
3.10.2.2 (IV) Indian N-Acetyl-Glucosamine Market	117
3.10.2.2 (V) South Korean N-Acetyl-Glucosamine Market	117
Exhibit 63. List of Asia-Pacific N-Acetyl-Glucosamine Companies	117
3.10.2.3 North American N-Acetyl-Glucosamine Market	118
Exhibit 64. N-Acetyl-Glucosamine – North American Value Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in US$ Million	118
Exhibit 65. N-Acetyl-Glucosamine – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	119
Exhibit 66. N-Acetyl-Glucosamine – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	120
Exhibit 67. N-Acetyl-Glucosamine – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	121
3.10.2.3 (I) US N-Acetyl-Glucosamine Market	121
3.10.2.3 (II) Canadian N-Acetyl-Glucosamine Market	121
Exhibit 68. List of North American N-Acetyl-Glucosamine Companies	121
3.10.2.4 European N-Acetyl-Glucosamine Market	123
Exhibit 69. N-Acetyl-Glucosamine – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia & Rest of Europe in US$ Thousands	123
Exhibit 70. N-Acetyl-Glucosamine – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	124
Exhibit 71. N-Acetyl-Glucosamine – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	125
Exhibit 72. N-Acetyl-Glucosamine – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	126
3.10.2.4 (I) UK N-Acetyl-Glucosamine Market	126
3.10.2.4 (II) German N-Acetyl-Glucosamine Market	126
3.10.2.4 (III) Spanish N-Acetyl-Glucosamine Market	126
3.10.2.4 (IV) Czech N-Acetyl-Glucosamine Market	127
3.10.2.4 (V) Russian N-Acetyl-Glucosamine Market	127
Exhibit 73. List of European N-Acetyl-Glucosamine Companies	127
3.10.2.5 Rest of World N-Acetyl-Glucosamine Market	128
Exhibit 74. N-Acetyl-Glucosamine – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in US$ Thousands	128
Exhibit 75. N-Acetyl-Glucosamine – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	129
Exhibit 76. N-Acetyl-Glucosamine – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in Metric Tons	130
Exhibit 77. N-Acetyl-Glucosamine – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for Israel, South Africa, Brazil and Other Countries	131
3.10.2.5 (I) South African N-Acetyl-Glucosamine Market	131
3.10.2.5 (II) Brazilian N-Acetyl-Glucosamine Market	131
3.10.2.5 (III) Israeli N-Acetyl-Glucosamine Market	131
3.11 Analysis by Applications	132
Exhibit 78. Glucosamine by Application - Global Value Market Analysis (2005-2020) for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and Other in US$ Million	132
Exhibit 79. Glucosamine by Application – Global Value Market Shares (2010, 2015 & 2020) for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and Other	133
Exhibit 80. Glucosamine by Application -Global Volume Market Estimations & Predictions (2005 - 2020) for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and Other in Metric Tons	134
Exhibit 81. Glucosamine by Application – Global Volume Market Shares (2010, 2015 & 2020) by Application for Nutraceutical/Pharmaceutical, Feed Additives, Food Ingredients and Other	135
3.11.1 Nutraceutical/Pharmaceutical	136
3.11.1.1 Global Market for Nutraceutical/Pharmaceutical in Glucosamine	136
Exhibit 82. Glucosamine in Nutraceutical/Pharmaceutical – Global Value Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	137
Exhibit 83. Glucosamine in Nutraceutical/Pharmaceutical – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	138
Exhibit 84. Glucosamine in Nutraceutical/Pharmaceutical – Global Volume Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	139
Exhibit 85. Glucosamine in Nutraceutical/Pharmaceutical – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	140
3.11.1.4 Asia-Pacific Market for Nutraceutical/Pharmaceutical in Glucosamine	141
Exhibit 86. Glucosamine in Nutraceutical/Pharmaceutical – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in US$ Thousands	141
Exhibit 87. Glucosamine in Nutraceutical/Pharmaceutical – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	142
Exhibit 88. Glucosamine in Nutraceutical/Pharmaceutical – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in Metric Tons	143
Exhibit 89. Glucosamine in Nutraceutical/Pharmaceutical – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	144
3.11.1.2 North American Market for Nutraceutical/Pharmaceutical in Glucosamine	145
Exhibit 90. Glucosamine in Nutraceutical/Pharmaceutical – North American Value Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in US$ Thousands	145
Exhibit 91. Glucosamine in Nutraceutical/Pharmaceutical – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	146
Exhibit 92. Glucosamine in Nutraceutical/Pharmaceutical – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	147
Exhibit 93. Glucosamine in Nutraceutical/Pharmaceutical – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	148
3.11.1.3 European Market for Nutraceutical/Pharmaceutical in Glucosamine	149
Exhibit 94. Glucosamine in Nutraceutical/Pharmaceutical – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in US$ Thousands	149
Exhibit 95. Glucosamine in Nutraceutical/Pharmaceutical – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	150
Exhibit 96. Glucosamine in Nutraceutical/Pharmaceutical – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	151
Exhibit 97. Glucosamine in Nutraceutical/Pharmaceutical – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	152
3.11.1.5 Rest of World Market for Nutraceutical/Pharmaceutical in Glucosamine	153
Exhibit 98. Glucosamine in Nutraceutical/Pharmaceutical – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in US$ Thousands	153
Exhibit 99. Glucosamine in Nutraceutical/Pharmaceutical – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	154
Exhibit 100. Glucosamine in Nutraceutical/Pharmaceutical – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in Metric Tons	155
Exhibit 101. Glucosamine in Nutraceutical/Pharmaceutical – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	156
3.11.2 Feed Additives	157
3.11.2.1 Global Market for Glucosamine in Feed Additives	157
Exhibit 102. Glucosamine in Feed Additives – Global Value Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	158
Exhibit 103. Glucosamine in Feed Additives – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	159
Exhibit 104. Glucosamine in Feed Additives – Global Volume Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	160
Exhibit 105. Glucosamine in Feed Additives – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	161
3.11.2.4 Asia-Pacific Market for Glucosamine in Feed Additives	162
Exhibit 106. Glucosamine in Feed Additives – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in US$ Thousands	162
Exhibit 107. Glucosamine in Feed Additives – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for Japan, Australia, India, China, South Korea and Rest of Asia-Pacific	163
Exhibit 108. Glucosamine in Feed Additives – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in Metric Tons	164
Exhibit 109. Glucosamine in Feed Additives – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	165
3.11.2.2 North America Market for Glucosamine in Feed Additives	166
Exhibit 110. Glucosamine in Feed Additives – North American Value Market Estimations & Predictions (2005 -2020) by Geographic Region for United States and Canada in US$ Thousands	166
Exhibit 111. Glucosamine in Feed Additives – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	167
Exhibit 112. Glucosamine in Feed Additives – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	168
Exhibit 113. Glucosamine in Feed Additives – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	169
3.11.2.3 European Market for Glucosamine in Feed Additives	170
Exhibit 114. Glucosamine in Feed Additives – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in US$ Thousands	170
Exhibit 115. Glucosamine in Feed Additives – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	171
Exhibit 116. Glucosamine in Feed Additives – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	172
Exhibit 117. Glucosamine in Feed Additives – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	173
3.11.2.5 Rest of World Market for Glucosamine in Feed Additives	174
Exhibit 118. Glucosamine in Feed Additives – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in US$ Thousands	174
Exhibit 119. Glucosamine in Feed Additives – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	175
Exhibit 120. Glucosamine in Feed Additives – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in Metric Tons	176
Exhibit 121. Glucosamine in Feed Additives – Rest of World Volume Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	177
3.11.3 Food Ingredients	178
3.11.3.1 Global Market for Glucosamine in Food Ingredients	178
Exhibit 122. Glucosamine in Food Ingredients – Global Value Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	179
Exhibit 123. Glucosamine in Food Ingredients – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	180
Exhibit 124. Glucosamine in Food Ingredients – Global Volume Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	181
Exhibit 125. Glucosamine in Food Ingredients – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	182
3.11.3.4 Asia-Pacific Market for Glucosamine in Food Ingredients	183
Exhibit 126. Glucosamine in Food Ingredients – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in US$ Thousands	183
Exhibit 127. Glucosamine in Food Ingredients – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	184
Exhibit 128. Glucosamine in Food Ingredients – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in Metric Tons	185
Exhibit 129. Glucosamine in Food Ingredients – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	186
3.11.3.2 North America Market for Glucosamine in Food Ingredients	187
Exhibit 130. Glucosamine in Food Ingredients – North American Value Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in US$ Thousands	187
Exhibit 131. Glucosamine in Food Ingredients – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	188
Exhibit 132. Glucosamine in Food Ingredients – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	189
Exhibit 133. Glucosamine in Food Ingredients – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	190
3.11.3.3 European Market for Glucosamine in Food Ingredients	191
Exhibit 134. Glucosamine in Food Ingredients – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in US$ Thousands	191
Exhibit 135. Glucosamine in Food Ingredients – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	192
Exhibit 136. Glucosamine in Food Ingredients – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	193
Exhibit 137. Glucosamine in Food Ingredients – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	194
3.11.3.5 Rest of World Market for Glucosamine in Food Ingredients	195
Exhibit 138. Glucosamine in Food Ingredients – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in US$ Thousands	195
Exhibit 139. Glucosamine in Food Ingredients – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	196
Exhibit 140. Glucosamine in Food Ingredients – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in Metric Tons	197
Exhibit 141. Glucosamine in Food Ingredients – Rest of World Volume Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	198
3.11.4 Other Applications	199
3.11.4.1 Global Market for Glucosamine in Other Applications	199
Exhibit 142. Glucosamine in Other Applications – Global Value Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in US$ Million	200
Exhibit 143. Glucosamine in Other – Global Value Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	201
Exhibit 144. Glucosamine in Other Applications – Global Volume Market Estimations & Predictions (2005 -2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World in Metric Tons	202
Exhibit 145. Glucosamine in Other Applications – Global Volume Market Shares (2010, 2015 & 2020) by Geographic Region for Asia-Pacific, North America, Europe and Rest of World	203
3.11.4.4 Asia-Pacific Market for Glucosamine in Other Applications	204
Exhibit 146. Glucosamine in Other Applications – Asia-Pacific Value Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in US$ Thousands	204
Exhibit 147. Glucosamine in Other Applications – Asia-Pacific Value Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	205
Exhibit 148. Glucosamine in Other Applications – Asia-Pacific Volume Market Estimations & Predictions (2005 -2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific in Metric Tons	206
Exhibit 149. Glucosamine in Other Applications – Asia-Pacific Volume Market Shares (2010, 2015 & 2020) by Country for China, Japan, Australia, India South Korea and Rest of Asia-Pacific	207
3.11.4.2 North American Market for Glucosamine in Other Applications	208
Exhibit 150. Glucosamine in Other Applications – North American Value Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in US$ Thousands	208
Exhibit 151. Glucosamine in Other Applications – North American Value Market Shares (2010, 2015 & 2020) by Country for United States and Canada	209
Exhibit 152. Glucosamine in Other Applications – North American Volume Market Estimations & Predictions (2005 -2020) by Country for United States and Canada in Metric Tons	210
Exhibit 153. Glucosamine in Other Applications – North American Volume Market Shares (2010, 2015 & 2020) by Country for United States and Canada	211
3.11.4.3 European Market for Glucosamine in Other Applications	212
Exhibit 154. Glucosamine in Other Applications – European Value Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in US$ Thousands	212
Exhibit 155. Glucosamine in Other Applications – European Value Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	213
Exhibit 156. Glucosamine in Other Applications – European Volume Market Estimations & Predictions (2005 -2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe in Metric Tons	214
Exhibit 157. Glucosamine in Other Applications – European Volume Market Shares (2010, 2015 & 2020) by Country for United Kingdom, Germany, Spain, Czech Republic, Russia and Rest of Europe	215
3.11.4.5 Rest of World Market for Glucosamine in Other Applications	216
Exhibit 158. Glucosamine in Other Applications – Rest of World Value Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in US$ Thousands	216
Exhibit 159. Glucosamine in Other Applications – Rest of World Value Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	217
Exhibit 160. Glucosamine in Other Applications – Rest of World Volume Market Estimations & Predictions (2005 -2020) by Country for South Africa, Brazil, Israel and Other Countries in Metric Tons	218
Exhibit 161. Glucosamine in Other Applications – Rest of World Volume Market Shares (2010, 2015 & 2020) by Country for South Africa, Brazil, Israel and Other Countries	219
3.12 Glucosamine – Market Outlook	220
IV. PRODUCT TECHNOLOGY/RESEARCH	223
4.1 Introduction	223
Glucosamine	223
Glucosamine Supplements	223
Biochemistry	224
Metabolism of Glucosamine Sulfate (GS)	224
Health Effects	225
Dosage	225
Side Effects of Glucosamine	225
Allergic Reactions	225
Anti-Allergic Glucosamine	225
Insulin Resistance	226
Gastrointestinal Complications	226
Side Effects of Glucosamine Sulfate	227
Increase in Sodium Intake	227
Side Effects of Chondroitin Glucosamine	227
Blood-Thinning Problems	227
Safety	227
Bioavailability and Pharmacokinetics	228
Mechanisms of Action	228
Applications	228
Forms of Glucosamine based Products	229
Liquid	229
Cream	229
Powder	230
Capsule	230
Gel	231
Tablet	231
Exhibit 162. List of Available Glucosamine based Drugs	232
4.2 Segmentation by Type	235
D-Glucosamine	235
Fermentation Process of Glucosamine	235
N-Acetyl-Glucosamine	241
Properties of N-Acetyl-Glucosamine	241
Fermentation Process of N-Acetyl-Glucosamine	242
N-Acetyl-Glucosamine Manufacturing Technology	244
The Process	245
Verification of N-Acetyl-Glucosamine Production	248
4.3 Segmentation by Application	248
Nutraceutical/Pharmaceutical	248
Glucosamine: Uses and Health Benefits	248
Knee Osteoarthritis (Mild to Moderate)	249
Osteoarthritis (General)	249
Chronic Venous Insufficiency	250
Inflammatory Bowel Disease (Crohn's Disease, Ulcerative Colitis)	250
Rheumatoid Arthritis	250
Temporomandibular Joint (TMJ) Disorders	250
Uses Based on Tradition or Theory	250
The Usage of Glucosamine for Arthritis and Hip Dysplasia	251
Feed Additives	252
Glucosamine for Animals	252
Dogs and Glucosamine Supplements	253
Glucosamine for Cats	253
Glucosamine Products for Horse	254
Food Ingredients	255
Vegetarian Glucosamine	255
Glucosamine as a Food Ingredient	255
GreenGrown Glucosamine	256
GlucosaGreen	256
Other	257
Application of N-Acetyl-Glucosamine in Cosmetology	257
Research Status	258
Glucosamine – Basic Therapy of Choice	259
Pharmacokinetics of Glucosamine in Man	259
Clinical Evaluation of Intra-Articular Glucosamine in Gonarthrosis (Knee Arthritis)	260
Conservative Management of Spinal Osteoarthritis with Glucosamine Sulfate	260
Glucosamine Sulfate Compared to Ibuprofen in Osteoarthritis of the Knee	260
Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthrosis	260
A Systematic Review	260
A comparative review	260
Antireactive Properties	261
Rules and Regulations for Manufacture, Distribution and Labeling of Glucosamine	261
Nutritional Supplements Certification Program	263
4.4 Glucosamine – Recent Research briefs	272
Glucosamine: A Longevity Extending Therapeutic and a Dietary Supplement	272
Sprifermin: Potential Curative Reducing Loss of Cartilage Associated with Osteoarthritis	272
Joints on Glucosamine (JOG) Study Findings Reveal No Beneficial Effects of Glucosamine on Joint Degeneration	273
Sugar Polymer of Multiple Pathogens on the Cell Surface may be Vital to the Development of Broad-spectrum Vaccine	274
Nylon From Shrimps	274
Glucosamine – New Uses	275
Novel bio adhesive polymer exhibited	276
Nano protects skin: Shrimp shell nanotech for healing wounds and anti-aging face cream	277
Joint Supplements for the Adverse Effects of Aromatase Inhibitor	277
Joint Supplements for the Adverse Effects of Aromatase Inhibitor	279
Glucosamine May Reduce Risk of Osteoarthritis	280
Glucosamine-like Supplement Used for Multiple Sclerosis Attacks	281
Mtech Maryland Industrial Partnerships Program Approves $4.2 Million to 15 new Technology Product Development Projects	282
Glucosamine of NutraSense, an Established Preparation for Joint Pain……	282
CE-C(4)D Method for Glucosamine Determination.	282
Lung Cancer Risk due to Glucosamine and Chondroitin	283
Role of Glucosamine in Vascular Contraction	284
Role of Glucosamine in Prostrate Cancer Cell	284
Role of GCM- Glucosamine-Chondroitin- and MSM diet in Obese Women	285
Mechanism behind Compound’s Effects on Skin Inflammation and Cancer Progression	286
Effect of Glucosamine administration in Dogs	287
Glucosamine and Osteoblastic Cell Differentiation	287
Oral Glucosamine Increases Expression of TGFβ1 AND CTGF mRNA in Rats	288
Glucosamine Enhances Atopic Dermatitis-Like Skin Lesions	288
Glucosamine sulfate and the Immunological Function	289
Effects of Glucosamine Derivatives in the Production of Glycosamine Glycans	289
Glucosamine effect on bone resorption and remodeling in murine collagenase-induced osteoarthritis:	290
Effects of glucosamine sulphate and chondroitin sulphate on focal cartilage damage	291
Effect of glucosamine, chondroitin and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease:	291
RNA ‘On/Off Switches’	292
LC - TMS for Determination of Glucosamine Concentration in Urine	293
Oral Glucosamine Use and the Effects on Glucose Metabolism in Normal Individuals as well as Diabetic Patients	294
Inhibition of EGF-Induced Proliferation and Cell Cycle Progression in Retinal Pigment Epithelial Cells by Glucosamine	295
Glucosamine Loss Enhances Intra Abdominal Fat, Serum Leptin Levels, as well as Insulin Resistance Induced by a High-Fat Diet in Rat Models	296
Glucosamine can bring about a Neuroprotective Effect through the Suppression of Inflammation in Rat Brain Ischemia/Reperfusion Injury	297
Glucosamine HCl as a Novel Carrier for Improved Dissolution Behavior: Effect of Grinding	298
From biomass to ethanol and methane-New enzyme may help to cheaper biofuel	299
Glucosamine Encourages Osteogenic Differentiation of Dental Pulp Stem Cells	299
Excess Glucosamine may Cause the death of Pancreatic Cells, Increase risk from Diabetes	299
Glucosamine, Chondroitin Does Not Assist Arthritis Patients	300
A Study Finds that Available Supplements to Combat Joint Pain Do not Work	301
Effects of glucosamine, chondroitin, or placebo in individuals with osteoarthritis of hip or knee: network meta-analysis	301
Phosphorylated glucosamine does inhibit the inflammatory response in LPS-stimulated PMA-differentiated THP-1 cells	303
Usage of Glucosamine does not Diminish the Requirement for other Pain-Relieving Drugs	303
Glucosamine Causes Autophagic Cell Death through Stimulation of ER stress in Human Glioma Cancer Cells	304
Glucosamine and Chronic LBP and OA	305
Glucosamine and Low Back Pain and Degenerative Lumbar Osteoarthritis	305
Glucosamine Performs Better on Knee Pain Compared to Back Pain	306
Study side-effects caused by Joint Health Supplements	306
Glucosamine Sulphate and Knee Osteoarthritis	307
Glucosamine Sulfate and Osteoarthritis and Nociception in Rats	308
First proof to show that chitosan could repair spinal damage	309
Effects of Chondroitin Sulfate and Glucosamine in Kaschin-Beck disease Patients	310
Recent study hints: “Walking Linked to Eased Osteoarthritis”	311
Analyzing the Effect of Glucosamine Administration on an Experimental Rat Osteoarthritis Model	311
A Feasibility Trial on Effectiveness of Progressive Walking Program and Glucosamine Sulphate Supplementation on Osteoarthritic Symptoms of the Hip and Knee	312
Analysis on the Safety on the Usage of Glucosamine Sulfate by Patients with a Restricted Dietary Potassium Intake	313
Glucosamine and Mesangial Cells of Kidney	313
Study Conducted to Analyze the Effects of Glucosamine-Chondroitin Sulfate Supplementation on Serum Fructosamine Concentration in Dogs	314
Application of Glucosamine Induced Autophagy Using an mTOR-independent pathway	314
Effects of Glucosamine and Celadrin on Functioning of Platelets	314
Glucosamine and In Vitro Fertilization [IVF]	315
Utilization of Palm Vitamin E and Glucosamine Sulphate in the Treatment of Osteoarthritis of the Knee	316
Glucosamine and Prostate Cancer	316
Evaluation of the Effect of Glucosamine Administration on Biomarkers for Cartilage and Bone Metabolism in Soccer Players	317
Glucosamine and Osteoarthritis	317
Effects of Oral Glucosamine on Joint Health: Is a change in research approach needed?	318
Differential Down-Regulation of COX-2 and MMP-13 in Human Skin Fibroblasts by Glucosamine-Hydrochloride	318
Glucosamine but not Ibuprofen Alters Cartilage turnover in Osteoarthritis Patients in response to Physical Training	319
Optimal 99mTc Radiolabeling and uptake of Glucosamine Sulfate by Cartilage	319
Glucosamine or Chondroitin Sulfate and Osteoarthritis	319
No Increase of Extracellular Matrix Production by Glucosamine Sulphate in the Presence of Low Oxygen Tension	320
Adipogenesis is Inhibited by Phosphorylated Glucosamine in 3T3-L1 Adipocytes	321
Increase in Insulin Resistance through Glucosamine in Fructose-Fed Rats	322
Response of Liver and Lymphocytes of the Mesenteric Lymph Nodes is Modulated by Oral Administration of Glucosamine in a Papain-Induced Model of Joint Damage and Repair	322
Glucosamine and Chondroitin Sulfate Useful in Knee Arthritis	323
Glucosamine Sulfate and Degenerated Patellar Cartilage	324
Combined Glucosamine/Chondroitin/Primorine Therapy for Osteoarthritis	324
High Performance Anion Exchange Chromatography to Measure Glucosamine Hydrochloride in Healthy Foods	325
Glucosamine Enhances Heart Function	326
Glucosamine, a Naturally Occurring Amino Monosaccharide, Suppresses Dextran Sulfate Sodium-Induced Colitis in Rats	326
Modulation of TNF-alpha-Induced Endothelial Cell Activation by Glucosamine	327
Inhibitory Effects of Glucosamine on Endotoxin- Induced Uveitis in Lewis Rats	327
Ineffectiveness of Glucosamine for Osteoarthritis	328
Glucosamine Increases Hyaluronic Acid Production in Human Osteoarthritic Synovium Explants	329
Effects of Clinically Relevant Concentration of Glucosamine on Equine Chondrocytes and Synoviocytes In Vitro	329
Effects of Methylprednisolone Acetate and Glucosamine on Proteoglycan Production by Equine Chondrocytes In Vitro	330
Inflammation of Joints Increases Glucosamine Levels attained in Synovial Fluid following Oral Administration of Glucosamine Hydrochloride	330
Glucosamine and its Role in Modulating LL-37-Induced Endothelial Cell Activation	331
Glucosamine Sulphate’s Effect on the Joint Space Narrowing and Pain	331
Process of Solid-Phase Synthesis of Alpha-Glucosamine Sulfoforms with Fragmentation Analysis by Tandem Mass Spectrometry	332
Analyzing the Effects of Glucosamine on Proteoglycan Loss by Tendon, Ligament and Joint Capsule Explant Cultures	332
Analysis to Better Understand the Therapeutic Results of Glucosamine Hydrochloride for Knee Degenerative Osteoarthritis (DOA)	333
Majority of the Methods Employed to treat Knee Osteoarthritis do not have a concrete Scientific Support	334
In Type 1 Diabetes, Supplement similar to Glucosamine Inhibits Multiple Sclerosis	335
Analysis to Better Understand the Effects of Glucosamine Sulfate on Intracellular UDP-Hexosamine and UDP-Glucuronic Acid Levels in Bovine Primary Chondrocytes	336
Process of Preparation of Glucosamine from Exoskeleton of Shrimp as well as predicting the Production Yield by Response Surface Method	336
Evaluation of Disease Modifying Effects of N-butyryl Glucosamine in a Streptococcal Cell Wall Induced Arthritis Model in Rats	337
Effect of Glucosamine Sulphate on the Blood Levels of Cholesterol or Triglycerides	337
Glucosamine Sulfate Promotes Osteoblastic Differentiation of MG-63 Cells via Anti-Inflammatory Effect	338
Predictors of Symptomatic Response to Glucosamine in Knee Osteoarthritis	338
Glucosamine-based Compounds Display Hemostatic Properties	338
Glucosamine Sulfate Inhibits Proinflammatory Cytokine-Induced ICAM-1 Production in Human Conjunctival Cells In Vitro	339
Effect of Glucosamine Concentration on the Development and Sex Ratio of Bovine Embryos	339
Glucosamine-Induced Increase in AKT Phosphorylation Corresponds to Increased Endoplasmic Reticulum Stress in Astroglial Cells	340
Exogenous Glucosamine Protects Chondrocytes from the Arthritogenic Effects of IL-1beta	340
Oral glucosamine for 6 weeks at Standard Doses does not Cause or Worsen Insulin Resistance or Endothelial Dysfunction in Lean or Obese Subjects	340
Clinical information on the Efficiency of Glucosamine and Chondroitin in the cure of Osteoarthritis	341
Rheumatoid Arthritis Patients to be Administered with Glucosamine	342
D-Glucosamine and its Derivatives Exhibit Antitumor Properties	342
Antioxidative and Immunostimulating Properties of D-Glucosamine	343
Oral Glucose Tolerance Test on Osteoarthritis Patients to analyze the effect of Oral Glucosamine Sulfate on Serum Glucose and Insulin	343
Introduction of Glucosamine at the time of Resuscitation Enhances the Organ Function Following Trauma Hemorrhage	344
Efficiency of Glucosamine/Chondroitin Sulfate for the Treatment of Osteoarthritis in Dogs	345
Glucose Maintenance by Glucosamine	345
Glucosamine and Chondroitin Sulfate Study Reveals Non-Impressive Results for Severe Osteoarthritis Knee Pain	346
Knee Osteoarthritis Treatment with Glucosamine, and Chondroitin Sulfate	347
Glucosamine-Induced Endoplasmic Reticulum Dysfunction is Related to Accelerated Atherosclerosis in Hyperglycemic Mouse Models	348
Inhibition of Platelet Activation in Guinea Pigs by Glucosamine	349
Glucosamine, a Potential Drug For Treating MS	350
Antioxidant Activity of Glucosamine Hydrochloride in an In Vitro Setting	351
Enumeration of Precise Effects of Glucose and Glucosamine on Vascular Endothelial and Smooth Muscle Cells	352
N-Acylation of Glucosamine does Modulate Chondrocyte Growth, Proteoglycan Synthesis, and Gene Expression	353
Effect of Glucosamine on the Growth and Hypertrophy of Mesangial Cells	355
Glucosamine Therapy for Osteoarthritis	355
Effect of Oral Glucosamine on Cartilage Degradation in a Rabbit Model of Osteoarthritis	356
Effects of Glucosamine Sulphate on Osteoarthritis	357
Glucosamine Induces Rapid Desensitization of Glucose Transport in Isolated Adipocytes by Increasing GlcN-6-P Levels	358
Preventive Properties of a High Dose of Glucosamine on Adjuvant Arthritis in Rats	358
Mannosamine has the ability to Replace Glucosamine in Glycosylphosphatidylinositols of Plasmodium Falciparum In Vitro	359
Preventive Properties of a High Dose of Glucosamine on Adjuvant Arthritis in Rats	360
Analysis of Glucosamine Hydrochloride Treatment on Osteoarthritis Patients	361
Combination of Glucosamine and Ibuprofen Discovered to be Effective for Pain Relief	362
Effects of Glucosamine Hydrochloride and Chondroitin Sulphate, Alone and in Combination, on Normal and Interleukin-1 Conditioned Equine Articular Cartilage Explant Metabolism	362
V. CORPORATE DIRECTORY	364
VI. PATENTS INFORMATION	406

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy